-
-
-
-
-
-
-
Form 8-K Launch One Acquisition For: Jun 02
-
-
-
-
-
-
-
Form SCHEDULE 13G/A Launch One Acquisition Filed by: MMCAP International Inc. SPC
-
-
-
-
-
-
-
Form 10-Q Launch One Acquisition For: Sep 30
-
-
-
-
-
-
-
Minovia Therapeutics Announces Interim Data from Phase 2 Trial in Pearson Syndrome Demonstrating No Treatment-Related Serious Adverse Events and Preliminary Signal for Efficacy Measured by Growth
-
-
-
-
-
-
-
Minovia Therapeutics Ltd. and Launch One Acquisition Corp. Announce Proposed Business Combination to Create Nasdaq-Listed Mitochondrial Therapy Company in $1 Trillion+ Mitochondrial and Longevity Mark
-
-
-
-
-
-
1,173,838 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

